Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 402

1.

Professor Sotorios Raptis.

Scherbaum WA.

Horm Metab Res. 2017 Nov;49(11):899. doi: 10.1055/s-0043-121469. Epub 2017 Nov 14. No abstract available.

PMID:
29136678
2.

Not a Population-Based Survey.

Kleinwechter H, Scherbaum WA, Schäfer-Graf U, Demandt N, Nolte A.

Dtsch Arztebl Int. 2017 Oct 13;114(41):690. doi: 10.3238/arztebl.2017.0690a. No abstract available.

3.

11-Keto-β-Boswellic Acid Inhibits Lymphocyte (CD3) Infiltration Into Pancreatic Islets of Young None Obese Diabetic (NOD) Mice.

Shehata AM, Quintanilla-Fend L, Bettio S, Kamyabi-Moghaddam Z, Kohlhofer UA, Scherbaum WA, Ammon HPT.

Horm Metab Res. 2017 Sep;49(9):693-700. doi: 10.1055/s-0043-112761. Epub 2017 Jul 31.

PMID:
28759942
4.

[The value of bariatric surgery in the treatment of diabetes : The STAMPEDE study].

Scherbaum WA, Nitschmann S.

Internist (Berl). 2017 Sep;58(9):1000-1003. doi: 10.1007/s00108-017-0290-4. Review. German. No abstract available.

PMID:
28721531
5.

Inverse Relationship Between Organ-Specific Autoantibodies and Systemic Immune Mediators in Type 1 Diabetes and Type 2 Diabetes: Action LADA 11.

Schloot NC, Pham MN, Hawa MI, Pozzilli P, Scherbaum WA, Schott M, Kolb H, Hunter S, Schernthaner G, Thivolet C, Seissler J, Leslie RD; Action LADA Group.

Diabetes Care. 2016 Nov;39(11):1932-1939. Epub 2016 Aug 29.

PMID:
27573939
6.

Long latency between GAD-antibody detection and development of limbic encephalitis--a case report.

Fauser S, Uttner I, Ariño H, Scherbaum WA, Saiz A, Lewerenz J.

BMC Neurol. 2015 Sep 30;15:177. doi: 10.1186/s12883-015-0435-9.

7.

[Therapy of diabetes mellitus in old age].

Scherbaum WA.

MMW Fortschr Med. 2015 Apr 30;157(8):39-43. doi: 10.1007/s15006-015-3030-5. Review. German. No abstract available.

PMID:
26012681
8.

11-Keto-β-Boswellic Acids Prevent Development of Autoimmune Reactions, Insulitis and Reduce Hyperglycemia During Induction of Multiple Low-Dose Streptozotocin (MLD-STZ) Diabetes in Mice.

Shehata AM, Quintanilla-Fend L, Bettio S, Jauch J, Scior T, Scherbaum WA, Ammon HP.

Horm Metab Res. 2015 Jun;47(6):463-9. doi: 10.1055/s-0035-1547293. Epub 2015 May 7.

PMID:
25951322
9.

Four-year evolution of insulin regimens, glycaemic control, hypoglycaemia and body weight after starting insulin therapy in type 2 diabetes across three continents.

Home PD, Dain MP, Freemantle N, Kawamori R, Pfohl M, Brette S, Pilorget V, Scherbaum WA, Vespasiani G, Vincent M, Balkau B.

Diabetes Res Clin Pract. 2015 May;108(2):350-9. doi: 10.1016/j.diabres.2015.01.030. Epub 2015 Jan 23.

10.

[Treatment of coma in diabetic ketoacidosis. Author reply].

Scherbaum WA, Scherbaum CR.

Med Klin Intensivmed Notfmed. 2015 Feb;110(1):77-8. German. No abstract available.

PMID:
25823363
11.

BMI is an important driver of β-cell loss in type 1 diabetes upon diagnosis in 10 to 18-year-old children.

Lauria A, Barker A, Schloot N, Hosszufalusi N, Ludvigsson J, Mathieu C, Mauricio D, Nordwall M, Van der Schueren B, Mandrup-Poulsen T, Scherbaum WA, Weets I, Gorus FK, Wareham N, Leslie RD, Pozzilli P.

Eur J Endocrinol. 2015 Feb;172(2):107-13. doi: 10.1530/EJE-14-0522. Epub 2014 Nov 6.

PMID:
25378371
12.

[Diabetes emergencies].

Scherbaum WA, Scherbaum CR.

Med Klin Intensivmed Notfmed. 2014 May;109(4):279-92; quiz 293-4. doi: 10.1007/s00063-013-0334-z. Review. German.

PMID:
24820043
13.

[Cardiovascular effects of a lifestyle intervention in type 2 diabetes. The Look AHEAD (Action for Health in Diabetes) study].

Scherbaum WA, Nitschmann S.

Internist (Berl). 2014 Jun;55(6):735-8. doi: 10.1007/s00108-014-3513-y. German. No abstract available.

PMID:
24817540
14.

Age-dependent decline of β-cell function in type 1 diabetes after diagnosis: a multi-centre longitudinal study.

Barker A, Lauria A, Schloot N, Hosszufalusi N, Ludvigsson J, Mathieu C, Mauricio D, Nordwall M, Van der Schueren B, Mandrup-Poulsen T, Scherbaum WA, Weets I, Gorus FK, Wareham N, Leslie RD, Pozzilli P.

Diabetes Obes Metab. 2014 Mar;16(3):262-7. doi: 10.1111/dom.12216. Epub 2013 Oct 29.

PMID:
24118704
15.

[Bariatric surgery and diabetes mellitus: pioneering studies from 2012 and consequences for treatment strategies].

Scherbaum WA, Nitschmann S.

Internist (Berl). 2013 May;54(5):639-44. doi: 10.1007/s00108-013-3274-z. German. No abstract available.

PMID:
23568061
16.

Adult-onset autoimmune diabetes in Europe is prevalent with a broad clinical phenotype: Action LADA 7.

Hawa MI, Kolb H, Schloot N, Beyan H, Paschou SA, Buzzetti R, Mauricio D, De Leiva A, Yderstraede K, Beck-Neilsen H, Tuomilehto J, Sarti C, Thivolet C, Hadden D, Hunter S, Schernthaner G, Scherbaum WA, Williams R, Brophy S, Pozzilli P, Leslie RD; Action LADA consortium.

Diabetes Care. 2013 Apr;36(4):908-13. doi: 10.2337/dc12-0931. Epub 2012 Dec 17. Erratum in: Diabetes Care. 2014 May;37(5):1494.

17.

Control of CYP11B2/CYP11B1 expression ratio and consequences for the zonation of the adrenal cortex.

Dringenberg T, Schwitalla M, Haase M, Scherbaum WA, Willenberg HS.

Horm Metab Res. 2013 Feb;45(2):81-5. doi: 10.1055/s-0032-1331210. Epub 2012 Dec 12.

PMID:
23235923
18.

False positives on both dexamethasone testing and urinary free cortisol in women on oral contraception: dose-response effects.

Paschali M, Willenberg HS, Fritzen R, Schott M, Scherbaum WA, Schinner S.

Clin Endocrinol (Oxf). 2013 Sep;79(3):443-4. doi: 10.1111/cen.12098. Epub 2013 Apr 19. No abstract available.

PMID:
23140463
19.

Localization and regulation of pancreatic selenoprotein P.

Steinbrenner H, Hotze AL, Speckmann B, Pinto A, Sies H, Schott M, Ehlers M, Scherbaum WA, Schinner S.

J Mol Endocrinol. 2012 Dec 31;50(1):31-42. doi: 10.1530/JME-12-0105. Print 2013 Feb.

PMID:
23125459
20.

Griseofulvin inhibits the growth of adrenocortical cancer cells in vitro.

Bramann EL, Willenberg HS, Hildebrandt B, Müller-Mattheis V, Schott M, Scherbaum WA, Haase M.

Horm Metab Res. 2013 Apr;45(4):297-300. doi: 10.1055/s-0032-1327642. Epub 2012 Oct 30.

PMID:
23111828
21.

HLA-A2 phenotype may be protective against Graves' disease but not against Hashimoto's thyroiditis in Caucasians.

Bernecker C, Ostapczuk M, Vordenbäumen S, Ehlers M, Thiel A, Schinner S, Willenberg H, Scherbaum WA, Schott M.

Horm Metab Res. 2013 Jan;45(1):74-7. doi: 10.1055/s-0032-1323704. Epub 2012 Sep 12.

PMID:
22972181
22.

Immunoregulatory natural killer cells suppress autoimmunity by down-regulating antigen-specific CD8+ T cells in mice.

Ehlers M, Papewalis C, Stenzel W, Jacobs B, Meyer KL, Deenen R, Willenberg HS, Schinner S, Thiel A, Scherbaum WA, Ullrich E, Zitvogel L, Schott M.

Endocrinology. 2012 Sep;153(9):4367-79. doi: 10.1210/en.2012-1247. Epub 2012 Jun 25.

PMID:
22733969
23.

Comparison of the saline infusion test and the fludrocortisone suppression test for the diagnosis of primary aldosteronism.

Willenberg HS, Vonend O, Schott M, Gao X, Blondin D, Saleh A, Rump LC, Scherbaum WA.

Horm Metab Res. 2012 Jun;44(7):527-32. doi: 10.1055/s-0032-1314786. Epub 2012 Jun 11.

PMID:
22689209
24.

Endothelin-1 and adrenomedullin plasma levels after exposure to fludrocortisone, dexamethasone, and spironolactone.

Vogt S, Winkler E, Hermsen D, Schott M, Schinner S, Scherbaum WA, Willenberg HS.

Clin Exp Hypertens. 2012;34(8):582-7. doi: 10.3109/10641963.2012.681729. Epub 2012 May 4.

PMID:
22559244
25.

Hypercortisolism caused by ritonavir associated inhibition of CYP 3A4 under inhalative glucocorticoid therapy. 2 case reports and a review of the literature.

Bernecker C, West TB, Mansmann G, Scherbaum WA, Willenberg HS.

Exp Clin Endocrinol Diabetes. 2012 Mar;120(3):125-7. doi: 10.1055/s-0031-1297993. Epub 2012 Feb 10. Review.

PMID:
22328106
26.

Evidence of a combined cytotoxic thyroglobulin and thyroperoxidase epitope-specific cellular immunity in Hashimoto's thyroiditis.

Ehlers M, Thiel A, Bernecker C, Porwol D, Papewalis C, Willenberg HS, Schinner S, Hautzel H, Scherbaum WA, Schott M.

J Clin Endocrinol Metab. 2012 Apr;97(4):1347-54. doi: 10.1210/jc.2011-2178. Epub 2012 Jan 18.

PMID:
22259066
27.

Increased serum concentrations of adhesion molecules but not of chemokines in patients with Type 2 diabetes compared with patients with Type 1 diabetes and latent autoimmune diabetes in adult age: action LADA 5.

Pham MN, Hawa MI, Roden M, Schernthaner G, Pozzilli P, Buzzetti R, Scherbaum WA, Seissler J, Hunter S, Leslie RD, Kolb H, Schloot NC; Action LADA Study Group.

Diabet Med. 2012 Apr;29(4):470-8. doi: 10.1111/j.1464-5491.2011.03546.x.

PMID:
22150724
28.

Evidence for an exercise induced increase of TNF-α and IL-6 in marathon runners.

Bernecker C, Scherr J, Schinner S, Braun S, Scherbaum WA, Halle M.

Scand J Med Sci Sports. 2013 Mar;23(2):207-14. doi: 10.1111/j.1600-0838.2011.01372.x. Epub 2011 Aug 9.

PMID:
22092703
29.

Adipocyte-secreted factors increase osteoblast proliferation and the OPG/RANKL ratio to influence osteoclast formation.

Kühn MC, Willenberg HS, Schott M, Papewalis C, Stumpf U, Flohé S, Scherbaum WA, Schinner S.

Mol Cell Endocrinol. 2012 Feb 26;349(2):180-8. doi: 10.1016/j.mce.2011.10.018. Epub 2011 Oct 25.

PMID:
22040599
30.

Exendin-4 upregulates the expression of Wnt-4, a novel regulator of pancreatic β-cell proliferation.

Heller C, Kühn MC, Mülders-Opgenoorth B, Schott M, Willenberg HS, Scherbaum WA, Schinner S.

Am J Physiol Endocrinol Metab. 2011 Nov;301(5):E864-72. doi: 10.1152/ajpendo.00144.2011. Epub 2011 Jul 19.

31.

A progressive increase in cardiovascular risk assessed by coronary angiography in non-diabetic patients at sub-diabetic glucose levels.

Schinner S, Füth R, Kempf K, Martin S, Willenberg HS, Schott M, Dinh W, Scherbaum WA, Lankisch M.

Cardiovasc Diabetol. 2011 Jun 24;10:56. doi: 10.1186/1475-2840-10-56.

32.

Cushing's disease in a patient with steroid 21-hydroxylase deficiency.

Haase M, Schott M, Kaminsky E, Lüdecke DK, Saeger W, Fritzen R, Schinner S, Scherbaum WA, Willenberg HS.

Endocr J. 2011;58(8):699-706. Epub 2011 Jun 4.

33.

Neuroendocrine neoplasms of the gastrointestinal tract.

Schott M, Klöppel G, Raffel A, Saleh A, Knoefel WT, Scherbaum WA.

Dtsch Arztebl Int. 2011 May;108(18):305-12. doi: 10.3238/arztebl.2011.0305. Epub 2011 May 6. Review.

34.

Subclinical hypothyroidism and the prevalence of the metabolic syndrome.

Liu C, Scherbaum WA, Schott M, Schinner S.

Horm Metab Res. 2011 Jun;43(6):417-21. doi: 10.1055/s-0031-1275719. Epub 2011 Apr 21.

PMID:
21512964
35.

Unconditioned and conditioned effects of intranasally administered insulin vs placebo in healthy men: a randomised controlled trial.

Stockhorst U, de Fries D, Steingrueber HJ, Scherbaum WA.

Diabetologia. 2011 Jun;54(6):1502-6. doi: 10.1007/s00125-011-2111-y. Epub 2011 Apr 2.

PMID:
21461638
36.

Pro- and anti-inflammatory cytokines in latent autoimmune diabetes in adults, type 1 and type 2 diabetes patients: Action LADA 4.

Pham MN, Hawa MI, Pfleger C, Roden M, Schernthaner G, Pozzilli P, Buzzetti R, Scherbaum WA, Seissler J, Kolb H, Hunter S, Leslie RD, Schloot NC; Action LADA Study Group.

Diabetologia. 2011 Jul;54(7):1630-8. doi: 10.1007/s00125-011-2088-6. Epub 2011 Feb 24. Erratum in: Diabetologia. 2012 Feb;55(2):534. Scherbaum, W [corrected to Scherbaum, W A].

PMID:
21347621
37.

Ceruloplasmin expression in rat liver cells is attenuated by insulin: role of FoxO transcription factors.

Leyendecker M, Korsten P, Reinehr R, Speckmann B, Schmoll D, Scherbaum WA, Bornstein SR, Barthel A, Klotz LO.

Horm Metab Res. 2011 Apr;43(4):268-74. doi: 10.1055/s-0031-1271692. Epub 2011 Feb 17.

PMID:
21332026
38.

Increased numbers of tumor-lysing monocytes in cancer patients.

Papewalis C, Jacobs B, Baran AM, Ehlers M, Stoecklein NH, Willenberg HS, Schinner S, Anlauf M, Raffel A, Cupisti K, Fenk R, Scherbaum WA, Schott M.

Mol Cell Endocrinol. 2011 Apr 30;337(1-2):52-61. doi: 10.1016/j.mce.2011.01.020. Epub 2011 Feb 1.

PMID:
21291954
39.

Unconditioned and conditioned effects of intravenous insulin and glucose on heart rate variability in healthy men.

Stockhorst U, Huenig A, Ziegler D, Scherbaum WA.

Physiol Behav. 2011 Apr 18;103(1):31-8. doi: 10.1016/j.physbeh.2011.01.014. Epub 2011 Jan 20.

PMID:
21256144
40.

[Supply of and participation in CME activities in the area served the north rhine chamber of physicians in Germany].

Rotthoff T, Baehring T, David DM, Bartnick C, Willers R, Linde F, Schäfer RD, Scherbaum WA.

Z Evid Fortbild Qual Gesundhwes. 2010;104(10):754-60. doi: 10.1016/j.zefq.2009.11.002. Epub 2009 Dec 21. German.

PMID:
21147439
41.
42.

A new mutation in the menin gene causes the multiple endocrine neoplasia type 1 syndrome with adrenocortical carcinoma.

Haase M, Anlauf M, Schott M, Schinner S, Kaminsky E, Scherbaum WA, Willenberg HS.

Endocrine. 2011 Apr;39(2):153-9. doi: 10.1007/s12020-010-9424-3. Epub 2010 Nov 11. Erratum in: Endocrine. 2011 Jun;39(3):298.

PMID:
21069576
43.

The value of training in communication skills for continuing medical education.

Rotthoff T, Baehring T, David DM, Bartnick C, Linde F, Willers R, Schäfer RD, Scherbaum WA.

Patient Educ Couns. 2011 Aug;84(2):170-5. doi: 10.1016/j.pec.2010.07.034. Epub 2010 Oct 2.

PMID:
20888726
44.

The effects of the endothelium on adrenal steroidogenesis and growth are mainly mediated by proteins other than endothelin-1.

Paramonova I, Haase M, Mülders-Opgenoorth B, Ansurudeen-Rafi I, Bornstein SR, Papewalis C, Schinner S, Schott M, Scherbaum WA, Willenberg HS.

Horm Metab Res. 2010 Nov;42(12):840-5. doi: 10.1055/s-0030-1265129. Epub 2010 Sep 13.

PMID:
20839150
45.

The CB-1 receptor antagonist rimonabant modulates the interaction between adipocytes and pancreatic beta-cells in vitro.

Ülgen F, Kühn MC, Cupisti K, Herder C, Willenberg HS, Schott M, Scherbaum WA, Schinner S.

Exp Clin Endocrinol Diabetes. 2011 Jan;119(1):41-6. doi: 10.1055/s-0030-1261963. Epub 2010 Jul 23.

PMID:
20658443
46.

[Therapy of obesity with liraglutide. NN8022-1807 study].

Scherbaum WA, Nitschmann S.

Internist (Berl). 2010 Aug;51(8):1064-6. doi: 10.1007/s00108-010-2694-2. German. No abstract available.

PMID:
20628715
47.

Chromogranin A as potential target for immunotherapy of malignant pheochromocytoma.

Papewalis C, Kouatchoua C, Ehlers M, Jacobs B, Porwol D, Schinner S, Willenberg HS, Anlauf M, Raffel A, Eisenhofer G, Neumann HP, Bornstein SR, Scherbaum WA, Schott M.

Mol Cell Endocrinol. 2011 Mar 15;335(1):69-77. doi: 10.1016/j.mce.2010.05.021. Epub 2010 Jun 22.

PMID:
20600588
48.

Indicators of mineralocorticoid excess in the evaluation of primary aldosteronism.

Balaş M, Zosin I, Maser-Gluth C, Hermsen D, Cupisti K, Schott M, Schinner S, Knoefel WT, Scherbaum WA, Willenberg HS.

Hypertens Res. 2010 Aug;33(8):850-6. doi: 10.1038/hr.2010.76. Epub 2010 Jun 3.

PMID:
20520614
49.

Association of serum levels of retinol-binding protein 4 with male sex but not with insulin resistance in obese patients.

Ulgen F, Herder C, Kühn MC, Willenberg HS, Schott M, Scherbaum WA, Schinner S.

Arch Physiol Biochem. 2010 May;116(2):57-62. doi: 10.3109/13813451003631421.

PMID:
20222849
50.

Sporadic solitary aldosterone- and cortisol-co-secreting adenomas: endocrine, histological and genetic findings in a subtype of primary aldosteronism.

Willenberg HS, Späth M, Maser-Gluth C, Engers R, Anlauf M, Dekomien G, Schott M, Schinner S, Cupisti K, Scherbaum WA.

Hypertens Res. 2010 May;33(5):467-72. doi: 10.1038/hr.2010.18. Epub 2010 Feb 26.

PMID:
20186151

Supplemental Content

Loading ...
Support Center